Edesa Biotech (NASDAQ:EDSA – Get Free Report) and Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Insider & Institutional Ownership 31.3% of Edesa […]